Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome

Keyphrases

• Clinical Outcomes 100%
• Apoptosis 100%
• Apoptosis Induction 100%
• Chronic Lymphocytic Leukemia 100%
• Bcl-2 Family Proteins 100%
• Bcl-2 Expression 100%
• Bcl-2 Gene 66%
• Clinical Features 33%
• Protein Expression 33%
• Cell Viability 33%
• Expression Level 33%
• High-level Expression 33%
• Untreated Patients 33%
• Immunoblot Analysis 33%
• Survival Analysis 33%
• B-cell Lymphoma 2 (Bcl-2) 33%
• Lymphoma Cells 33%
• Chronic Lymphocytic Leukemia Cells 33%
• Peripheral Blood Lymphocytes 33%
• Short-term Culture 33%
• Apoptotic Cell Death 33%
• DNA Fragmentation Assay 33%
• Adverse Features 33%
• Inter-patient Variability 33%
• Prognostic Information 33%
• Transcriptional Deregulation 33%

Neuroscience

• Programmed Cell Death 100%
• Bcl-2 100%
• Protein Bcl 2 60%
• In Vitro 40%
• Proto Oncogene 40%
• Cell Line 20%
• Immunoblotting 20%
• Lymphocyte 20%
• Protein Expression 20%
• DNA Fragmentation 20%
• Cell Viability 20%